glp 1 drugs in development GLP-1R Agonists for Weight Loss GLP-1 Receptor Agonist Shortage: Challenges
Description
Pancreatitis There is a known, although rare, risk of acute pancreatitis with GLP-1RAs
This process can take days to weeks, creating supply gaps that trigger weight regain if not managed proactively
Cao Y, Holscher C, Hu MM, Wang T, Zhao F, Bai Y, et al
These effects occurred in 4070% of treated patients in clinical trials
Higher effective doses: The dosing regimen allows for greater total GLP-1 receptor activation
For medications treating chronic conditions like obesity, long-term safety data accumulates after approval through post-market surveillance
